Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Targets high-growth eye care expansion push
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
Subscribe To Our Newsletter & Stay Updated